Vimeo
LinkedIn
Instagram
Share |

investment

October 15, 2021

In the 26 years that Ruffer LLP has been in existence, a clear pattern has emerged. When the market mood is either complacent or ebullient, equity indices tend to rise strongly, and we lag behind them. An ‘unexpected’ crisis then hits, and Ruffer quickly recovers lost ground.

In the 26 years that Ruffer LLP has been in existence, a clear pattern has emerged. When the market mood is either complacent or ebullient, equity indices tend to rise strongly, and we lag behind them. An ‘unexpected’ crisis then hits, and Ruffer quickly recovers lost ground.

October 13, 2021

Exclusive proposals for early-stage healthcare companies fund, a novel esophagus therapy, a hybrid-electric airship and sustainable investments in water conservation will be heard by qualifying family offices and private investors at the latest virtual Campden Wealth Funds and Direct Investments Event on 21 October.

Exclusive proposals for early-stage healthcare companies fund, a novel esophagus therapy, a hybrid-electric airship and sustainable investments in water conservation will be heard by qualifying family offices and private investors at the latest virtual Campden Wealth Funds and Direct Investments Event on 21 October.

Each of the four investment opportunities will be introduced in 15-minute slots to all family offices and investors online who will be able to ask questions and discuss the potential returns.

October 6, 2021

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

We are pleased to report that in our mission to alleviate pain, restore health and extend life, we have had a positive impact on more than 72 million patients during the year despite pandemic-related challenges.

October 1, 2021

The Covid-19 delta variant, inflation and central bank tapering are unnerving investors. We expect the pandemic-recovery trade to resume as inflation subsides, infection rates decline and tapering turns out to not equal tightening.

The Covid-19 delta variant, inflation and central bank tapering are unnerving investors. We expect the pandemic-recovery trade to resume as inflation subsides, infection rates decline and tapering turns out to not equal tightening.

Amid this backdrop, our outlook favours equities over bonds, the value factor over the growth factor and non-US stocks over US stocks.

Key market themes

October 1, 2021

In the world of investment, there are few things everyone can agree on. You’re either a bull or a bear, a dove or a hawk, for or against.

In the world of investment, there are few things everyone can agree on. You’re either a bull or a bear, a dove or a hawk, for or against.

If there’s one thing investors do know for sure—it’s that bonds and equities can be used in combination to achieve a ‘balanced portfolio’.

At the simplest level, this means building portfolios with some equities for the good times, and bonds for the bad. Typically, in a 60/40 split.

September 30, 2021

An innovative successor fund investing in resilient agri-food excellence in Italy will be presented by Amundi to family investors at the Campden Wealth Family Office and Investment Forum in Geneva on 6-7 October, 2021.

An innovative successor fund investing in resilient agri-food excellence in Italy will be presented by Amundi to family investors at the Campden Wealth Family Office and Investment Forum in Geneva on 6-7 October, 2021.

September 29, 2021

Early-stage solutions for strokes, varicose veins, surgical 3D imaging, wounds, skincare and genomic screenings are among the breakthroughs to be showcased for ambitious investors at the virtual MedTech Investing Europe Forum on 13-14 October.

Early-stage solutions for strokes, varicose veins, surgical 3D imaging, wounds, skincare and genomic screenings are among the breakthroughs to be showcased for ambitious investors at the virtual MedTech Investing Europe Forum on 13-14 October.

September 22, 2021

The European Union’s regulation of medical devices in Europe only began in the 1990s. Previously, member states acted independently, but the differing national requirements were replaced by EU directives including the 1993 Medical Devices Directive (MDD) and the 1998 In Vitro Diagnostics Directive (IVDD). 

The European Union’s regulation of medical devices in Europe only began in the 1990s. Previously, member states acted independently, but the differing national requirements were replaced by EU directives including the 1993 Medical Devices Directive (MDD) and the 1998 In Vitro Diagnostics Directive (IVDD).

September 21, 2021

What can they see that we can’t? Private equity bids for UK companies are soaring, while at the same time the UK stock market languishes at valuations well below US peers.

What can they see that we can’t? Private equity bids for UK companies are soaring, while at the same time the UK stock market languishes at valuations well below US peers.

Private equity bids for UK companies are soaring, while at the same time the UK stock market languishes at valuations well below US peers.

Click here >>
Close